The trademark application HYFINODI was filed by Checkpoint Therapeutics Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on October 25, 2022, and it was registered by office on February 1, 2023 without any oppositions.
The application was filed in English (German was selected as the second language).